Latest On Kindred Biosciences, Inc (KIN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-07-21 13:32 EST | News | Kindred Biosciences shares rise on positive KIND-030 parvovirus study results | N/A |  |
| 2021-07-21 13:26 EST | News | Kindred Biosciences (KIN) Investor Presentation - Slideshow | N/A | |
| 2021-07-21 13:26 EST | News | Kindred Bio stock soars 43% on deal to be bought by Elanco for $440M | N/A | |
| 2021-07-21 13:26 EST | News | Opthea, Kindred Biosciences leads healthcare gainers; Inhibikase Therapeutics, Paratek Pharmaceuticals among major losers | N/A | |
| 2021-07-21 13:25 EST | News | Elanco deal for Kindred could better position company against Zoetis - Barron's | N/A | |
| 2021-04-28 17:00 EST | News | USDA accepts Kindred data for parvovirus biologic candidate; shares up 3% | N/A | |
| 2021-04-21 01:47 EST | News | Kindred posts positive results from long-acting interleukin-31 antibody PK study | N/A | |
| 2021-03-26 11:06 EST | News | Kindred Biosciences may be deal target after results on Tirnovetmab, CEO says | N/A | |
| 2021-03-17 13:02 EST | Earnings Estimate | An EPS average of -$0.50 is estimated for the 2022 year. | Sell | |
| 2021-03-17 13:02 EST | Earnings Estimate | An EPS average of -$0.22 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-17 13:02 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-17 02:41 EST | News | Kindred Biosciences EPS in-line, misses on revenue | N/A | |
| 2021-03-17 02:41 EST | News | Kindred Biosciences, Inc. (KIN) CEO Richard Chin on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-26 02:51 EST | News | Kindred submits efficacy data to support KIND-030 prophylactic indication approval | N/A | |
| 2021-01-10 23:53 EST | Analyst Rating | The Analyst Target Price has decreased from $11.18 to $10.89. | Neutral | |
| 2021-01-06 15:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-21 10:35 EST | News | Kindred Biosciences announces positive results for antibody therapy | N/A | |
| 2020-12-21 04:27 EST | Analyst Rating | The Analyst Target Price has decreased from $11.32 to $11.18. | Neutral | |
| 2020-12-12 01:07 EST | News | Elanco buys rights to KindredBio's canine parvovirus therapy | N/A | |
| 2020-12-02 12:19 EST | Analyst Rating | The Analyst Target Price has decreased from $11.64 to $11.32. | Neutral | |
| 2020-11-26 20:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 02:08 EST | News | Kindred Biosciences suspends feline recombinant erythropoietin program | N/A | |
| 2020-11-11 12:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 17:29 EST | News | Kindred Biosciences EPS misses by $0.01, beats on revenue | N/A | |
| 2020-11-10 17:28 EST | News | Kindred Biosciences, Inc. (KIN) CEO Richard Chin on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-10 12:21 EST | Earnings Estimate | An EPS average of -$0.18 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-07 16:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 21:38 EST | Insider Trade | Denise Bevers has disposed of 12,508 shares indirectly via SD Scientific, Inc.. | Sell | |
| 2020-10-08 21:38 EST | Insider Trade | Denise Bevers has acquired 12,508 shares indirectly via SD Scientific, Inc.. | Buy | |
| 2020-10-07 21:16 EST | News | Vaxart and Kindred Bio expand manufacturing agreement for COVID-19 vaccine candidates | N/A | |
| 2020-09-26 13:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-24 18:52 EST | Insider Trade | Denise Bevers has disposed of 515 shares indirectly via SD Scientific, Inc.. | Sell | |
| 2020-09-24 18:52 EST | Insider Trade | Denise Bevers has acquired 515 shares indirectly via SD Scientific, Inc.. | Buy | |
| 2020-09-17 05:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 23:12 EST | News | Kindred's antibody shows efficacy and mortality benefit against canine parvovirus | N/A | |
| 2020-08-14 09:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-08 19:20 EST | News | Kindred Biosciences, Inc.'s (KIN) CEO Richard Chin on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-08 05:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-05 17:16 EST | News | Kindred Biosciences EPS beats by $0.47, beats on revenue | N/A | |
| 2020-08-03 21:23 EST | Insider Trade | Denise Bevers has directly acquired 40,000 shares and currently holds 203,333 shares. | Buy | |
| 2020-08-03 21:23 EST | Insider Trade | Denise Bevers has directly acquired 55,000 shares and currently holds 163,333 shares. | Buy | |
| 2020-07-31 01:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 13:03 EST | Analyst Rating | The Analyst Target Price has decreased from $13.64 to $11.64. | Neutral | |
| 2020-07-23 17:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-30 22:07 EST | Insider Trade | Park West Asset Management LLC has indirectly disposed of 115,136 shares. | Sell | |
| 2020-06-26 09:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 05:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-08 23:44 EST | News | Kindred Bio to downsize in cost-cutting move | N/A | |
| 2020-06-02 05:11 EST | Earnings Estimate | An EPS average of -$0.36 is estimated for the quarter ending on September 30, 2020. | Buy | |
About Kindred Biosciences, Inc (KIN):
Kindred Biosciences, Inc., a biopharmaceutical company, is developing biologics that focus on the lives of pets. The company has a pipeline of novel biologics in development across various therapeutic classes and intellectual property portfolio. Its programs under development include interleukin-31 and interleukin-4R for canine atopic dermatitis; KIND-030 for parvovirus in dogs; KIND-510a for the control of non-regenerative anemia in cats; anti-TNF antibody for inflammatory bowel disease in dogs; and other biologics candidates. The company was founded in 2012 and is headquartered in Burlingame, California.
General
- Name Kindred Biosciences, Inc
- Symbol KIN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Fiscal Year EndDecember
- IPO Date2013-12-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.kindredbio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 4.51
- Price/Book (Most Recent Quarter) 2.53
- Enterprise Value Revenue 3.71
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.63
- Next Year EPS Estimate -$0.64
- Next Quarter EPS Estimate -$0.18
- Profit Margin -52%
- Operating Margin -37%
- Return on Assets -9%
- Return on Equity -29%
- Revenue 42.16 million
- Earnings Per Share -$1.63
- Revenue Per Share $1.07
- Gross Profit 37.54 million
- Quarterly Earnings Growth 2730.2%
View More
Highlights
- Market Capitalization 205.59 million
- EBITDA -59615000
- PEG Ratio -0.16
- Analyst Target Price $10.89
- Book Value Per Share $1.71
View More
Share Statistics
- Shares Outstanding 41.45 million
- Shares Float 32.19 million
- % Held by Insiders 616%
- % Held by Institutions 67.9%
- Shares Short 1.1 million
- Shares Short Prior Month 992496
- Short Ratio 1.9
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 1.18
- 52 Week High $6
- 52 Week Low $3.11
- 50 Day Moving Average 4.89
- 200 Day Moving Average 4.45
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Kindred Biosciences, Inc (KIN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Kindred Biosciences, Inc (KIN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | -$0.28 | -$0.29 | 3.45% |
| 2020-09-30 | 2020-11-09 | $N/A | -$0.30 | -$0.31 | 1.72% |
| 2020-06-30 | 2020-08-05 | $N/A | $0.66 | $0.16 | 323.81% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.45 | -$0.43 | -4.81% |
| 2019-12-31 | 2020-03-16 | $1.4 million | -$0.40 | -$0.40 | 0.42% |
| 2019-09-30 | 2019-11-12 | $1.1 million | -$0.39 | -$0.37 | -5.81% |
| 2019-06-30 | 2019-08-01 | $1.24 million | -$0.37 | -$0.38 | 3.37% |
| 2019-03-31 | 2019-05-09 | $515000 | -$0.42 | -$0.40 | -4.48% |
| 2018-12-31 | 2019-03-06 | $1.33 million | -$0.46 | -$0.46 | 0% |
| 2018-09-30 | 2018-11-07 | $640000 | -$0.39 | -$0.38 | -1.56% |
| 2018-06-30 | 2018-08-09 | $N/A | -$0.39 | -$0.39 | -0.52% |
| 2018-03-31 | 2018-05-08 | $N/A | -$0.36 | -$0.36 | -0.56% |
| 2017-12-31 | 2018-03-01 | $N/A | -$0.35 | -$0.31 | -13.64% |
| 2017-09-30 | 2017-11-07 | $N/A | -$0.29 | -$0.33 | 11.23% |
| 2017-06-30 | 2017-08-07 | $N/A | -$0.29 | -$0.32 | 9.38% |
| 2017-03-31 | 2017-05-03 | $N/A | -$0.30 | -$0.34 | 11.76% |
| 2016-12-31 | 2017-03-01 | $N/A | -$0.29 | -$0.36 | 19.44% |
| 2016-09-30 | 2016-11-07 | $N/A | -$0.29 | -$0.31 | 6.45% |
| 2016-06-30 | 2016-08-08 | $N/A | -$0.25 | -$0.32 | 20.63% |
| 2016-03-31 | 2016-05-05 | $N/A | -$0.27 | -$0.32 | 14.84% |
| 2015-12-31 | 2016-03-02 | $N/A | -$0.32 | -$0.44 | 27.81% |
| 2015-09-30 | 2015-11-09 | $N/A | -$0.36 | -$0.44 | 18.18% |
| 2015-06-30 | 2015-08-10 | $N/A | -$0.35 | -$0.44 | 20.45% |
| 2015-03-31 | 2015-05-08 | $N/A | -$0.34 | -$0.41 | 17.07% |
| 2014-12-31 | 2015-03-12 | $N/A | -$0.34 | -$0.43 | 20.93% |
| 2014-09-30 | 2014-11-13 | $N/A | -$0.31 | -$0.45 | 31.11% |
| 2014-06-30 | 2014-08-13 | $N/A | -$0.42 | -$0.35 | -20% |
| 2014-03-31 | 2014-05-12 | $N/A | -$0.38 | -$0.18 | -111.11% |
| 2013-12-31 | 2014-03-06 | $N/A | -$0.40 | -$0.20 | -100% |
Kindred Biosciences, Inc (KIN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Kindred Biosciences, Inc (KIN) Chart:
Kindred Biosciences, Inc (KIN) News:
Below you will find a list of latest news for Kindred Biosciences, Inc (KIN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Kindred Biosciences, Inc (KIN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Kindred Biosciences, Inc (KIN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000678/0000905718-20-000678-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000021545719006578/0000215457-19-006578-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000021545719007505/0000215457-19-007505-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000083423720008148/0000834237-20-008148-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000089542119000106/0000895421-19-000106-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000089542120000161/0000895421-20-000161-index.htm |
| 2018-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571818000474/0000905718-18-000474-index.htm |
| 2018-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571818000596/0000905718-18-000596-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571819000067/0000905718-19-000067-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000090571819000226/0000905718-19-000226-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000238/0000905718-20-000238-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000514/0000905718-20-000514-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000518/0000905718-20-000518-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000529/0000905718-20-000529-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000531/0000905718-20-000531-index.htm |
| 2020-06-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000678/0000905718-20-000678-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000093675319000047/0000936753-19-000047-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000093675320000060/0000936753-20-000060-index.htm |
| 2018-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000070/0001250853-18-000070-index.htm |
| 2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000074/0001250853-18-000074-index.htm |
| 2018-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000077/0001250853-18-000077-index.htm |
| 2018-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000078/0001250853-18-000078-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000079/0001250853-18-000079-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000092/0001250853-18-000092-index.htm |
| 2018-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000093/0001250853-18-000093-index.htm |
| 2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000095/0001250853-18-000095-index.htm |
| 2018-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000111/0001250853-18-000111-index.htm |
| 2018-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000121/0001250853-18-000121-index.htm |
| 2018-09-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000125/0001250853-18-000125-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000126/0001250853-18-000126-index.htm |
| 2018-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000134/0001250853-18-000134-index.htm |
| 2018-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000135/0001250853-18-000135-index.htm |
| 2018-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000137/0001250853-18-000137-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000145/0001250853-18-000145-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000020/0001250853-19-000020-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000033/0001250853-19-000033-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000034/0001250853-19-000034-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000035/0001250853-19-000035-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000036/0001250853-19-000036-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000038/0001250853-19-000038-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000039/0001250853-19-000039-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000040/0001250853-19-000040-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000041/0001250853-19-000041-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000042/0001250853-19-000042-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000043/0001250853-19-000043-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000044/0001250853-19-000044-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000045/0001250853-19-000045-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000046/0001250853-19-000046-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000026/0001250853-20-000026-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000027/0001250853-20-000027-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000028/0001250853-20-000028-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000029/0001250853-20-000029-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000030/0001250853-20-000030-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000031/0001250853-20-000031-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000032/0001250853-20-000032-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000033/0001250853-20-000033-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000034/0001250853-20-000034-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000036/0001250853-20-000036-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000037/0001250853-20-000037-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000038/0001250853-20-000038-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000039/0001250853-20-000039-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000041/0001250853-20-000041-index.htm |
| 2020-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000061/0001250853-20-000061-index.htm |
| 2020-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000085/0001250853-20-000085-index.htm |
| 2020-10-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000086/0001250853-20-000086-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000149315219018883/0001493152-19-018883-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000149315220002219/0001493152-20-002219-index.htm |
| 2018-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000034/0001561743-18-000034-index.htm |
| 2018-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000035/0001561743-18-000035-index.htm |
| 2018-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000037/0001561743-18-000037-index.htm |
| 2018-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000041/0001561743-18-000041-index.htm |
| 2018-05-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000042/0001561743-18-000042-index.htm |
| 2018-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000047/0001561743-18-000047-index.htm |
| 2018-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000048/0001561743-18-000048-index.htm |
| 2018-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000054/0001561743-18-000054-index.htm |
| 2018-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000057/0001561743-18-000057-index.htm |
| 2018-06-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000060/0001561743-18-000060-index.htm |
| 2018-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000064/0001561743-18-000064-index.htm |
| 2018-06-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000067/0001561743-18-000067-index.htm |
| 2018-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000070/0001561743-18-000070-index.htm |
| 2018-07-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000073/0001561743-18-000073-index.htm |
| 2018-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000077/0001561743-18-000077-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000079/0001561743-18-000079-index.htm |
| 2018-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000082/0001561743-18-000082-index.htm |
| 2018-10-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000084/0001561743-18-000084-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000086/0001561743-18-000086-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000090/0001561743-18-000090-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174318000092/0001561743-18-000092-index.htm |
| 2019-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000003/0001561743-19-000003-index.htm |
| 2019-01-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000012/0001561743-19-000012-index.htm |
| 2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000013/0001561743-19-000013-index.htm |
| 2019-01-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000018/0001561743-19-000018-index.htm |
| 2019-01-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000019/0001561743-19-000019-index.htm |
| 2019-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000021/0001561743-19-000021-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000024/0001561743-19-000024-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000029/0001561743-19-000029-index.htm |
| 2019-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000030/0001561743-19-000030-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000034/0001561743-19-000034-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000036/0001561743-19-000036-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000039/0001561743-19-000039-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000041/0001561743-19-000041-index.htm |
| 2019-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000044/0001561743-19-000044-index.htm |
| 2019-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000046/0001561743-19-000046-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000049/0001561743-19-000049-index.htm |
| 2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000052/0001561743-19-000052-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000053/0001561743-19-000053-index.htm |
| 2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000057/0001561743-19-000057-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000061/0001561743-19-000061-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174319000063/0001561743-19-000063-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000002/0001561743-20-000002-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000007/0001561743-20-000007-index.htm |
| 2020-03-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000009/0001561743-20-000009-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000017/0001561743-20-000017-index.htm |
| 2020-04-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000018/0001561743-20-000018-index.htm |
| 2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000022/0001561743-20-000022-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000027/0001561743-20-000027-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000028/0001561743-20-000028-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000033/0001561743-20-000033-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000035/0001561743-20-000035-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000041/0001561743-20-000041-index.htm |
| 2020-05-12 | 8-A12B/A | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000043/0001561743-20-000043-index.htm |
| 2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000045/0001561743-20-000045-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000051/0001561743-20-000051-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000053/0001561743-20-000053-index.htm |
| 2020-07-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000058/0001561743-20-000058-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000064/0001561743-20-000064-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000066/0001561743-20-000066-index.htm |
| 2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000070/0001561743-20-000070-index.htm |
| 2020-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1561743/000156174320000072/0001561743-20-000072-index.htm |
| 2018-06-06 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1561743/999999999718006190/9999999997-18-006190-index.htm |
| 2018-09-13 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1561743/999999999718007850/9999999997-18-007850-index.htm |
Kindred Biosciences, Inc (KIN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kindred Biosciences, Inc (KIN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 616%Institutional Ownership: 6790%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-22 | Denise Bevers | Director | Sell | 515.00 | 5.00 | 2,575.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000085/0001250853-20-000085-index.htm |
| 2020-10-07 | Denise Bevers | Director | Sell | 12,508.00 | 5.01 | 62,627.56 | 0.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000086/0001250853-20-000086-index.htm |
| 2019-01-22 | Denise Bevers | President and COO | Buy | 27,500.00 | 116,130.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000033/0001250853-19-000033-index.htm | ||
| 2018-10-29 | ERNEST MARIO | Director | Buy | 833.00 | 1.37 | 1,141.21 | 125,000.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000135/0001250853-18-000135-index.htm |
| 2020-10-07 | Denise Bevers | Director | Buy | 12,508.00 | 0.32 | 4,002.56 | 12,508.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000086/0001250853-20-000086-index.htm |
| 2020-01-22 | Denise Bevers | President and COO | Buy | 27,500.00 | 125,487.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000038/0001250853-20-000038-index.htm | ||
| 2020-07-31 | Denise Bevers | Director | Buy | 55,000.00 | 163,333.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000061/0001250853-20-000061-index.htm | ||
| 2018-10-29 | ERNEST MARIO | Director | Buy | 44,000.00 | 3.45 | 151,800.00 | 169,000.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000135/0001250853-18-000135-index.htm |
| 2019-01-02 | Richard Chin | Chief Executive Officer | Sell | 40,000.00 | 10.57 | 422,716.00 | 1,906,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000020/0001250853-19-000020-index.htm |
| 2019-01-22 | Richard Chin | Chief Executive Officer | Buy | 37,500.00 | 1,943,571.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000036/0001250853-19-000036-index.htm | ||
| 2018-12-03 | Richard Chin | Chief Executive Officer | Sell | 40,000.00 | 13.28 | 531,200.00 | 1,946,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000145/0001250853-18-000145-index.htm |
| 2020-02-11 | Richard Chin | Chief Executive Officer | Buy | 12,500.00 | 1,951,705.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000041/0001250853-20-000041-index.htm | ||
| 2020-01-22 | Richard Chin | Chief Executive Officer | Buy | 37,500.00 | 1,959,457.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000037/0001250853-20-000037-index.htm | ||
| 2018-11-01 | Richard Chin | CEO | Sell | 40,000.00 | 14.68 | 587,200.00 | 1,986,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000137/0001250853-18-000137-index.htm |
| 2018-10-01 | Richard Chin | President and CEO | Sell | 40,000.00 | 13.28 | 531,200.00 | 2,026,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000126/0001250853-18-000126-index.htm |
| 2020-07-31 | Denise Bevers | Director | Buy | 40,000.00 | 203,333.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000061/0001250853-20-000061-index.htm | ||
| 2018-09-05 | Richard Chin | PRESIDENT AND CEO | Sell | 7,600.00 | 14.69 | 111,644.00 | 2,066,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000121/0001250853-18-000121-index.htm |
| 2018-09-04 | Richard Chin | PRESIDENT AND CEO | Sell | 32,400.00 | 14.81 | 479,844.00 | 2,073,671.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000121/0001250853-18-000121-index.htm |
| 2018-08-01 | Richard Chin | President and CEO | Sell | 40,000.00 | 13.51 | 540,400.00 | 2,106,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000111/0001250853-18-000111-index.htm |
| 2018-07-02 | Richard Chin | President and CEO | Sell | 40,000.00 | 10.28 | 411,200.00 | 2,146,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000095/0001250853-18-000095-index.htm |
| 2018-06-01 | Richard Chin | President and CEO | Sell | 40,000.00 | 10.13 | 405,200.00 | 2,186,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000079/0001250853-18-000079-index.htm |
| 2018-05-30 | Richard Chin | President and CEO | Sell | 12,610.00 | 10.00 | 126,100.00 | 2,226,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000079/0001250853-18-000079-index.htm |
| 2018-05-25 | Richard Chin | President and CEO | Sell | 3,000.00 | 10.00 | 30,000.00 | 2,238,681.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000078/0001250853-18-000078-index.htm |
| 2018-05-24 | Richard Chin | President and CEO | Sell | 60.00 | 10.00 | 600.00 | 2,241,681.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000078/0001250853-18-000078-index.htm |
| 2018-05-18 | Richard Chin | President and CEO | Sell | 2,400.00 | 10.00 | 24,000.00 | 2,241,741.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000077/0001250853-18-000077-index.htm |
| 2018-05-09 | Richard Chin | President and CEO | Sell | 200.00 | 10.00 | 2,000.00 | 2,244,141.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000074/0001250853-18-000074-index.htm |
| 2018-05-07 | Richard Chin | President and CEO | Sell | 1,730.00 | 10.01 | 17,317.30 | 2,244,341.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000074/0001250853-18-000074-index.htm |
| 2018-05-01 | Richard Chin | President and CEO | Sell | 20,000.00 | 9.05 | 181,000.00 | 2,246,071.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000070/0001250853-18-000070-index.htm |
| 2018-09-26 | Raymond Townsend | Director | Sell | 2,885.00 | 13.30 | 38,370.50 | 24,928.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000125/0001250853-18-000125-index.htm |
| 2018-09-25 | Raymond Townsend | Director | Sell | 115.00 | 13.80 | 1,587.00 | 27,813.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085318000125/0001250853-18-000125-index.htm |
| 2019-01-22 | Hangjun Zhan | Chief Scientific Officer | Buy | 6,250.00 | 39,397.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000034/0001250853-19-000034-index.htm | ||
| 2020-01-22 | Hangjun Zhan | Chief Scientific Officer | Buy | 6,250.00 | 41,210.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000036/0001250853-20-000036-index.htm | ||
| 2019-01-22 | Wendy Wee | Chief Financial Officer | Buy | 7,500.00 | 43,733.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085319000035/0001250853-19-000035-index.htm | ||
| 2020-01-22 | Wendy Wee | Chief Financial Officer | Buy | 7,500.00 | 48,726.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000039/0001250853-20-000039-index.htm | ||
| 2020-09-22 | Denise Bevers | Director | Buy | 515.00 | 0.32 | 164.80 | 515.00 | https://www.sec.gov/Archives/edgar/data/1561743/000125085320000085/0001250853-20-000085-index.htm |
| 2018-06-20 | Park West Asset Management LLC | 10% Share Holder | Buy | 845,262.00 | 9.50 | 8,029,989.00 | 6,002,053.00 | https://www.sec.gov/Archives/edgar/data/1561743/000090571818000596/0000905718-18-000596-index.htm |
| 2020-06-26 | Park West Asset Management LLC | 10% Share Holder | Sell | 115,136.00 | 4.71 | 542,290.56 | 6,628,757.00 | https://www.sec.gov/Archives/edgar/data/1561743/000090571820000678/0000905718-20-000678-index.htm |
| 2019-01-18 | Park West Asset Management LLC | 10% Share Holder | Buy | 741,840.00 | 9.50 | 7,047,480.00 | 6,743,893.00 | https://www.sec.gov/Archives/edgar/data/1561743/000090571819000067/0000905718-19-000067-index.htm |